Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study

[This corrects the article DOI: 10.1371/journal.pone.0184550.].

Saved in:
Bibliographic Details
Published inPloS one Vol. 13; no. 6; p. e0199926
Main Authors Buti, María, Manzano, María L, Morillas, Rosa M, García-Retortillo, Montserrat, Martín, Leticia, Prieto, Martín, Gutiérrez, María L, Suárez, Emilio, Rubio, Mariano Gómez, López, Javier, Castillo, Pilar, Rodríguez, Manuel, Zozaya, José M, Simón, Miguel A, Morano, Luis E, Calleja, José L, Yébenes, María, Esteban, Rafael
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 25.06.2018
Public Library of Science (PLoS)
Subjects
Activation
Health risk assessment
Hepatitis
Hepatitis B
Prophylaxis
Rituximab
Tenofovir
Viruses
Online AccessGet full text

Cover

More Information
Summary:[This corrects the article DOI: 10.1371/journal.pone.0184550.].
Bibliography:correction
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correction/Retraction-1
ObjectType-Feature-3
content type line 23
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0199926